RecruitingNot ApplicableNCT06505447

PICU-related Sleep and Circadian Dysregulation Pilot Study

A Three-phase Pilot Study of the Feasibility of the Measurement and Promotion of Sleep and the Circadian Rhythm in a Pediatric Intensive Care Unit


Sponsor

State University of New York at Buffalo

Enrollment

30 participants

Start Date

Dec 6, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

A single center pilot trial investigating the feasibility of using actigraphy and salivary melatonin levels to measure the sleep and circadian rhythm of critically ill children aged 3 to 6 years old. This study will also measure the feasibility of providing daytime light exposure as well as restricting all provided nutrition to during daytime hours.


Eligibility

Min Age: 3 YearsMax Age: 6 Years

Inclusion Criteria3

  • Child age 3 to 6 years old on the day of PICU admission
  • English-speaking parent at the bedside
  • Child expected to remain in the PICU over 24 to 48 hours

Exclusion Criteria3

  • Child is in end-of-life care
  • The child is receiving neuromuscular blockade for any reason
  • Caregiver or parent not at the bedside

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDaytime light exposure

Participants will be exposed to a 10,000 lux light source within 3 feet of their face/eyes to promote the natural circadian rhythm for 2-3 hours from 10am to 12/1pm depending on their nap time at home

OTHERDaytime restricted feeding

Participant's nutrition, parenteral or enteral, will be restricted to the hours when they are normally awake at home.


Locations(1)

John R. Oishei Children's Hospital

Buffalo, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06505447


Related Trials